Alligator Bioscience AB (ATORX.ST)

Every figure this model derived for ATORX.ST, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2024-12-31
cash 64,310,000 CashAndCashEquivalents 2025-01-01
current assets 71,396,000 CurrentAssets 2025-01-01
current liabilities 201,451,000 CurrentLiabilities 2025-01-01
equity -130,588,000 Equity 2025-01-01
interest expense 20,343,000 FinanceCosts 2024-12-31
ocf -212,426,000 CashFlowsFromUsedInOperatingActivities 2024-12-31
revenue 57,767,000 RevenueFromContractsWithCustomers 2024-12-31
sbc 59,000 AdjustmentsForSharebasedPayments 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up ATORX.ST on one particular measure came for.

RatioValue
cash operating margin-396.56
current ratio0.35
current ratio reported0.35
fcf margin-367.73
interest cover-11.26
operating margin-396.66
owner earnings margin-367.83
revenue growth-0.59
revenue growth per share-0.59
rule of 40-397.25
sbc pct revenue0.1

What to be careful about

What this model itself distrusts about ATORX.ST's figures. Written by the derivation as it ran, not added afterwards.